AU673591B2 - Photoprotected bacillus thuringiensis toxin - Google Patents
Photoprotected bacillus thuringiensis toxin Download PDFInfo
- Publication number
- AU673591B2 AU673591B2 AU63081/94A AU6308194A AU673591B2 AU 673591 B2 AU673591 B2 AU 673591B2 AU 63081/94 A AU63081/94 A AU 63081/94A AU 6308194 A AU6308194 A AU 6308194A AU 673591 B2 AU673591 B2 AU 673591B2
- Authority
- AU
- Australia
- Prior art keywords
- photoprotectant
- produces
- microorganism
- compound
- melanin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 241000193388 Bacillus thuringiensis Species 0.000 title claims description 9
- 229940097012 bacillus thuringiensis Drugs 0.000 title claims description 9
- 239000003053 toxin Substances 0.000 title description 11
- 231100000765 toxin Toxicity 0.000 title description 11
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 claims description 119
- 244000005700 microbiome Species 0.000 claims description 53
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 43
- 150000001875 compounds Chemical class 0.000 claims description 43
- 239000002158 endotoxin Substances 0.000 claims description 39
- 241000588724 Escherichia coli Species 0.000 claims description 35
- 238000000034 method Methods 0.000 claims description 35
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 claims description 29
- 239000000203 mixture Substances 0.000 claims description 27
- 230000000749 insecticidal effect Effects 0.000 claims description 22
- 108020004414 DNA Proteins 0.000 claims description 17
- 108060008724 Tyrosinase Proteins 0.000 claims description 17
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 claims description 17
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 claims description 17
- 235000021466 carotenoid Nutrition 0.000 claims description 16
- 239000013598 vector Substances 0.000 claims description 16
- 241000894006 Bacteria Species 0.000 claims description 14
- 230000009466 transformation Effects 0.000 claims description 13
- 102000003425 Tyrosinase Human genes 0.000 claims description 11
- 108010053835 Catalase Proteins 0.000 claims description 10
- 150000001747 carotenoids Chemical class 0.000 claims description 10
- 230000005855 radiation Effects 0.000 claims description 10
- 235000000177 Indigofera tinctoria Nutrition 0.000 claims description 8
- 229940097275 indigo Drugs 0.000 claims description 8
- COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 claims description 8
- 238000001228 spectrum Methods 0.000 claims description 8
- 230000002103 transcriptional effect Effects 0.000 claims description 8
- 108010028143 Dioxygenases Proteins 0.000 claims description 7
- 241000238631 Hexapoda Species 0.000 claims description 7
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 claims description 5
- 239000004480 active ingredient Substances 0.000 claims description 5
- 230000002950 deficient Effects 0.000 claims description 5
- 108020004511 Recombinant DNA Proteins 0.000 claims description 4
- 230000001105 regulatory effect Effects 0.000 claims description 4
- 230000001131 transforming effect Effects 0.000 claims description 4
- 241000255925 Diptera Species 0.000 claims description 3
- 241000255777 Lepidoptera Species 0.000 claims description 3
- 230000001276 controlling effect Effects 0.000 claims description 3
- 230000014621 translational initiation Effects 0.000 claims description 3
- 241000254173 Coleoptera Species 0.000 claims description 2
- 239000004615 ingredient Substances 0.000 claims description 2
- 102000016938 Catalase Human genes 0.000 claims 9
- 125000001895 carotenoid group Chemical group 0.000 claims 6
- 102000016680 Dioxygenases Human genes 0.000 claims 5
- 210000004027 cell Anatomy 0.000 description 45
- 108090000623 proteins and genes Proteins 0.000 description 33
- 108700012359 toxins Proteins 0.000 description 19
- 239000013612 plasmid Substances 0.000 description 10
- 238000004166 bioassay Methods 0.000 description 9
- 239000013078 crystal Substances 0.000 description 9
- 238000004520 electroporation Methods 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 239000012634 fragment Substances 0.000 description 7
- 239000000499 gel Substances 0.000 description 7
- 230000004224 protection Effects 0.000 description 7
- 235000014469 Bacillus subtilis Nutrition 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 230000028070 sporulation Effects 0.000 description 6
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 5
- 239000006137 Luria-Bertani broth Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 5
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 4
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 4
- 241000661337 Chilo partellus Species 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 241000233866 Fungi Species 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 4
- 108020004707 nucleic acids Proteins 0.000 description 4
- 102000039446 nucleic acids Human genes 0.000 description 4
- 150000007523 nucleic acids Chemical class 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 241000195493 Cryptophyta Species 0.000 description 3
- 101710151559 Crystal protein Proteins 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241000589516 Pseudomonas Species 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- 241000186988 Streptomyces antibioticus Species 0.000 description 3
- 244000309466 calf Species 0.000 description 3
- 229940041514 candida albicans extract Drugs 0.000 description 3
- 238000010367 cloning Methods 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- 239000002773 nucleotide Substances 0.000 description 3
- 125000003729 nucleotide group Chemical group 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 235000021251 pulses Nutrition 0.000 description 3
- 238000001262 western blot Methods 0.000 description 3
- 239000012138 yeast extract Substances 0.000 description 3
- NKDFYOWSKOHCCO-YPVLXUMRSA-N 20-hydroxyecdysone Chemical compound C1[C@@H](O)[C@@H](O)C[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@@](C)(O)[C@H](O)CCC(C)(O)C)CC[C@]33O)C)C3=CC(=O)[C@@H]21 NKDFYOWSKOHCCO-YPVLXUMRSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 244000063299 Bacillus subtilis Species 0.000 description 2
- 241000193365 Bacillus thuringiensis serovar israelensis Species 0.000 description 2
- 238000007399 DNA isolation Methods 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 102000003960 Ligases Human genes 0.000 description 2
- 108090000364 Ligases Proteins 0.000 description 2
- -1 Mycosporine amino acid Chemical class 0.000 description 2
- 229930193140 Neomycin Natural products 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 241000316848 Rhodococcus <scale insect> Species 0.000 description 2
- 238000002105 Southern blotting Methods 0.000 description 2
- 229920004890 Triton X-100 Polymers 0.000 description 2
- 239000013504 Triton X-100 Substances 0.000 description 2
- 229960000723 ampicillin Drugs 0.000 description 2
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000000853 biopesticidal effect Effects 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000009089 cytolysis Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000002779 inactivation Effects 0.000 description 2
- 238000013507 mapping Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 2
- 238000010369 molecular cloning Methods 0.000 description 2
- 229960004927 neomycin Drugs 0.000 description 2
- FSVCQIDHPKZJSO-UHFFFAOYSA-L nitro blue tetrazolium dichloride Chemical compound [Cl-].[Cl-].COC1=CC(C=2C=C(OC)C(=CC=2)[N+]=2N(N=C(N=2)C=2C=CC=CC=2)C=2C=CC(=CC=2)[N+]([O-])=O)=CC=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=C([N+]([O-])=O)C=C1 FSVCQIDHPKZJSO-UHFFFAOYSA-L 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 230000000886 photobiology Effects 0.000 description 2
- 230000003711 photoprotective effect Effects 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- FSCGLKWYHHSLST-UHFFFAOYSA-N 2-(3-sulfanylpropanoylamino)acetic acid Chemical compound OC(=O)CNC(=O)CCS FSCGLKWYHHSLST-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 244000291564 Allium cepa Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- 241000228245 Aspergillus niger Species 0.000 description 1
- 108700003918 Bacillus Thuringiensis insecticidal crystal Proteins 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 102100035882 Catalase Human genes 0.000 description 1
- 241000192703 Chlorogloeopsis Species 0.000 description 1
- 244000045195 Cicer arietinum Species 0.000 description 1
- 235000010523 Cicer arietinum Nutrition 0.000 description 1
- 241000661278 Eldana saccharina Species 0.000 description 1
- PLUBXMRUUVWRLT-UHFFFAOYSA-N Ethyl methanesulfonate Chemical compound CCOS(C)(=O)=O PLUBXMRUUVWRLT-UHFFFAOYSA-N 0.000 description 1
- 244000207620 Euterpe oleracea Species 0.000 description 1
- 235000012601 Euterpe oleracea Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 241000255893 Pyralidae Species 0.000 description 1
- 101100478210 Schizosaccharomyces pombe (strain 972 / ATCC 24843) spo2 gene Proteins 0.000 description 1
- CGZKSPLDUIRCIO-UHFFFAOYSA-N Scytonemin Natural products OC1=CC=C(C=C1)C=C1C(C(=C2C1=NC=1C=CC=CC2=1)C=1C(C(C2=NC=3C=CC=CC=3C2=1)=CC1=CC=C(C=C1)O)=O)=O CGZKSPLDUIRCIO-UHFFFAOYSA-N 0.000 description 1
- 241000892502 Streptomyces lividans 1326 Species 0.000 description 1
- 241001655322 Streptomycetales Species 0.000 description 1
- 108010058907 Tiopronin Proteins 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 230000006750 UV protection Effects 0.000 description 1
- SZCBXWMUOPQSOX-LOFNIBRQSA-N Violaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C12OC1(C)CC(O)CC2(C)C)C=CC=C(/C)C=CC34OC3(C)CC(O)CC4(C)C SZCBXWMUOPQSOX-LOFNIBRQSA-N 0.000 description 1
- 239000004213 Violaxanthin Substances 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 235000003650 acai Nutrition 0.000 description 1
- 229960004308 acetylcysteine Drugs 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 239000001058 brown pigment Substances 0.000 description 1
- 239000006229 carbon black Substances 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000001332 colony forming effect Effects 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000001056 green pigment Substances 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 230000016784 immunoglobulin production Effects 0.000 description 1
- 229940072221 immunoglobulins Drugs 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 150000002475 indoles Chemical class 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000000974 larvacidal effect Effects 0.000 description 1
- 230000001418 larval effect Effects 0.000 description 1
- 230000002934 lysing effect Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000002231 mosquitocidal effect Effects 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 239000003471 mutagenic agent Substances 0.000 description 1
- 231100000707 mutagenic chemical Toxicity 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 235000008476 powdered milk Nutrition 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 210000001938 protoplast Anatomy 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 108020004418 ribosomal RNA Proteins 0.000 description 1
- CGZKSPLDUIRCIO-RPCRKUJJSA-N scytonemin Chemical compound C1=CC(O)=CC=C1\C=C\1C2=NC3=CC=CC=C3C2=C(C=2C(C(=C/C=3C=CC(O)=CC=3)/C=3C=2C2=CC=CC=C2N=3)=O)C/1=O CGZKSPLDUIRCIO-RPCRKUJJSA-N 0.000 description 1
- 229940076279 serotonin Drugs 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 239000012192 staining solution Substances 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- 229960004402 tiopronin Drugs 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000010361 transduction Methods 0.000 description 1
- 230000026683 transduction Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- SZCBXWMUOPQSOX-PSXNNQPNSA-N violaxanthin Chemical compound C(\[C@@]12[C@](O1)(C)C[C@H](O)CC2(C)C)=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/[C@]1(C(C[C@@H](O)C2)(C)C)[C@]2(C)O1 SZCBXWMUOPQSOX-PSXNNQPNSA-N 0.000 description 1
- 235000019245 violaxanthin Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/32—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
- C07K14/325—Bacillus thuringiensis crystal peptides, i.e. delta-endotoxins
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
- A01N63/20—Bacteria; Substances produced thereby or obtained therefrom
- A01N63/22—Bacillus
- A01N63/23—B. thuringiensis
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
- A01N63/50—Isolated enzymes; Isolated proteins
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Dentistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Virology (AREA)
- Biotechnology (AREA)
- Agronomy & Crop Science (AREA)
- Wood Science & Technology (AREA)
- Environmental Sciences (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Description
-M
AUSTRALIA
Patents Act 1990 COMPLETE SPECIFICATION STANDARD PATENT Applicant(s): AECI LIMITED Invention Title: PHOTOPROTECTED BACILLUS THURINGIENSIS
TOXIN
The following statement is a full ,iscription of this invention, including the best method of performing it known to z-ie/us: BACKGROUND OF THE INVENTION THIS invention relates to the protection against photodegredation of either an endotoxin of a strain of Bacillus thuringiensis(Bt) or the Bt cells per se, or the spores obtained from cultures of the Bt cells after sporogenesis.
Bt is a Gram positive bacterium which produces crystal protein inclusions known as protoxins, endotoxins or deita-endotoxins. These crystals have insecticidal activity with a high degree of specificity. The crystal protein production is initiated during stage II of sporulation, after which time the cells complete sporulation and lyse, releasing spores and crystals into the culture medium.
The spores/crystals preparations have been used for many years as biopesticides. However, there are some problems with the longevity of the Bt crystals in the field. One of these is the sensitivity of the crystals to ultraviolet radiation, which results in inactivation of the toxin. As the South African environment in particular has a very high incidence of sunlight, the ability to protect the crystals from uv-damage is important. To this end, many commercial preparations of Bt are formulated to include chemicals that provide some degree of uv protection. Hov. ,ver, to date these preparations have not been very effective and increase the costs of formulation.
An article entitled "Protection from Ultraviolet Irradiation by Melanin of Mosquitocidal Activity of Bacillus thuringiensis var. israelensis", in the Journal of Invertebrate Pathology, 62, 131-136, 1993, by Yu-Tien Leu, Meng-Jiun Sui, Dar-Der Ji, I-Haun Wu, Chin-Chi Chou and Cheng-Chen Chen, discloses the efficacy of melanin in the protection of mosquito larvacidal activity of Bacillus thuringiensis var. israelensis against uv light. The melanin is produced by the fermentation of Streptomyces lividans 66 which contains a recombinant plasmid pIJ702 bearing a tyrosinase gene, and is then isolated and purified.
Thereafter an appropriate amount of the melanin powdei is added into a Bt spore suspension or delta-endotoxin preparation. The spore suspension and the delta-endotoxin preparation containing various amounts of melanin were treated with different doses of uv radiation at 253 nm wave lengths. The survival of bacteria before and after the uv radiation was measured by counting the colony forming units. Bioassay results showed that the melanin was effective as a photoprotection agent for Bt spores and the delta-endotoxin thereof. At the end of the article it is stated that the authors consider melanin to be an excellent photoprotector and could be used in protecting delta-endotoxin or other uv-sensitive substances. However, when the preparation of Bt var. israelensis is applied in the field, melanin may be easily washed off by water. To solve this problem, the studies of sub-cloning and expression of tyrosinase gene from streptomycete in the cells of Bt var.
israelensis will be carried out.
It is an object of this invention to provide a microorganism which contains in its genome both a DNA sequence which encodes a Bt endotoxin and a DNA sequence which encodes a compound which either acts as a photoprotectant or which produces a photoprotectant.
SUMMARY OF THE INVENTION According to a first aspect of the invention there is provided a microorganism containing in its genome a first DNA sequence encoding a Bacillus thuringiensis endotoxin and a second DNA sequence encoding a compound which either acts as a photoprotectant or which produces a photoprotectant, the first and second DNA sequences being capable of expression in the microorganism.
i s I I The second DNA sequence may encode a compound which acts as a photoprotectant. An example of this is a carotenoid.
Alternatively the second DNA sequence may encode a compound which produces a photoprotectant. For example the compound may be an enzyme which acts on or converts a substrate to produce the photoprotectant.
Examples of this are the enzyme tyrosinase which converts tyrosine into the photoprotectant melanin, or the enzyme en:oded by the indole dioxygenase gene isolated from Rhodococcus, which produces the photoprotectant indigo.
The photoprotectant may act as a photoprotectant for the microorganism cells themselves and/or for the spores obtained from cultures of the cells after sporogenesis and/or for the endotoxin produced by the microorganism cells.
The microorganism may be any suitable microorganism including a bacterium, a fungi, an algae or a yeast. The microorganism is preferably a bacterium such as for example a strain of Bacillus thuringiensis, a strain of Bacillus subtilis, a strain of Escherichia coli (E.coli), or a strain of Pseudomonas.
Obviously, when the microorganism is a strain of Bt itself, the Bt will already include in its genome a DNA sequence encoding a Bt endotoxin.
When the microorganism is a strain of Bt, the strain is preferably asporogenous and/or autolysin deficient. Alternatively, the Bt cells can be encapsulated or the cell walls can be cross-linked using, eg. gluteraldehyde.
The photoprotectant preferably absorbs radiation i-i the uv and 300-380 nm region of the spectrum.
According to a second aspect of the invention there is provided a microorganism transformation vector carrying an expression cassette including a DNA sequence encoding a compound which either acts as a photoprotectant or which produces a photoprotectant, and a promoter and optionally a I terminator.
The transformation vector may be f. r example a Bt transformation vector.
According to a third aspect of the invention there is provided a microorganism transformation vector carrying an expression cassette including a first DNA sequence encoding a Bt endotoxin and a second DNA sequence encoding a compound which either acts as a photoprotectant or which produces a photoprotectant, at least one promoter and optionally a terminator for each DNA sequence.
The microorganism transformation vector as described above may be used for example for transformation of a B.subtilis, E.coli or Pseudomonas cell.
According to a fourth aspect of the invention there is provided a method of producing a microorganism which expresses a Bt endotoxin and a compound which either acts as a photoprotectant or which produces a photoprotectant including the step of transforming a cell of the microorganism by inserting into the genome of the cell a first DNA sequence encoding a Bt endotoxin and a second DNA sequence encoding a compound which either acts as a photoprotectant or which produces a photoprotectant under the transcriptional and translational control of transcriptional and translational initiation and termination regulatory regions which function in the microorganism.
According to a fifth aspect of the invention there is provided a method of conferring resistance to photodegredation on a strain of Bt including transforming a cell of the Bt strain by inserting into the genome of the Bt cell a DNA sequence which encodes for a compound which either acts as a photoprotectant or which produces a photoprotectant under the transcriptional and translational control of transcriptional and translatinnal initiation and termination regulatory regions which function in the Bt cell.
According to a sixth aspect of the invention there is provided an insecticidal i composition containing as its active ingredient a Bt endotoxin and a photoprotectant, the Bt endotoxin and the photoprotectant or a compound which produces the photoprotectant having been expressed by the same microorganism.
According to a seventh aspect of the invention there is provided an insecticidal composition containing as its active ingredient a strain of Bt which includes in its genome a DNA sequence encoding a compound which either acts as a photoprotectant or which produces a photoprotectant, and/or the spores obtained from a culture of the Bt strain after sporogenesis and/or an endotoxin produced by the Bt strain after sporogenesis.
According to an eighth aspect of the invention there is provid .d a method for controlling insects, for example of the order Lepidoptera, Diptera or Coleoptera at a locus which includes the step of treating the locus to be protected with an amount of an insecticidal composition as described above.
According to a ninth aspect of the invention there is provided a recombinant DNA sequence comprising a first DNA sequence encoding a Bt endotoxin and a second DNA sequence encoding a compound which either acts as a photoprotectant or which produces a photoprotectant.
DESCRIPTION OF EMBODIMENTS The sunlight-mediated inactivation of the delta-endotoxin crystals produced by strains of Bt affects both the efficacy and economics of Bt as a biopesticide.
It has previously been established that some pigments provide protection against uv-damage and for this reason, they are often added to formulations of spores and delta-endotoxin crystals of Bt for application in the field.
Examples of compounds which have been added for this purpose are carbon black and melanin. However, these compounds have not been found to be entirely successful as they do not appear to coat the delta-endotoxin crysta!s adequately, and may wash off.
The present invention provides a microorganism which contains in its genome a first DNA sequence encoding a Bt endotoxin and a second DNA sequence encoding a compound which either acts as a photoprotectant or which produces a photoprotectant, the first and second DNA sequences being capable of expression in the microorganism.
More particularly, the present invention provides a strain of Bt, preferably a commercial strain of Bt, having inserted into its genome a DNA sequence which encodes a compound which either acts as a photoprotectant or which produces a photoprotectant. This will enable the transformed strain of Bt to provide its own protection against photodegredation.
The photoprotectant may act as a photoprotectant for the microorganism cells, eg the Bt cells, per se, and/or for the spores obtained from the cultures of the cells after sporogenesis and/or for the endotoxin produced by the cells after sporogenesis.
Suitable compounds which may act as photoprotectants or radical scavengers include: Melanin which is produced by the enzyme tyrosinase by conversion of tyrosine, as well as melanin from other sources such as fungi, other bacteria and yeasts (Geis and Szaniszlo, Mycologia, 76(2) (1984) 268- 273; P Roy, K K Nayak and N K Pandey, J. Gen. Microbiol. (1989) 135, 3385-3391).
Indoles such as indigo which is produced by an enzyme encoded by the indole dioxygenase gene isolated from Rhodococcus (S Hart and D R Woods, J Gen. Micro (1992) 138, 205-209).
Carotenoids from algae, for example violaxanthin (H Senger, E I 8 Schrader and N I Bishop, Bot. Acta. 106(1993), 72-77), from fungi and bacteria ar e Flavonoids and related phenolic compou; Braun and M Trevini, Photochemnistry and Photobiology, 57 t8-323 (199.5)).
Thiol containing compounds, e g N-acetylcysteine, mercaptopropionylglycine and captorpril (LT Van Den Broeke, G M J Beyersbergen van Henegouwen, .I Photochern. Photobiol. B:Biol., 17 (1993 279 286).
Water soluble fraction of onion pigment (K Shinohara, S Iwatsuki, M Kobori, Nippon Shokuhin Kogyo Gakkaishi, Vol. 40(2), 144-149(1993)).
Cysteine and ATP (TRK Reddy, K Sarada, Phykos (1982), 21 108-114).
Serotonin from Candida. (Strakhovskaya et Izv. Akad. Nauk. SSSR, Ser. Biol. 1982(4) 624-030).
Tryptophan. (Larcomn et Photochem. Photobiol. (1981) 34 583- 587).
Green pigments in spores of Aspergillus (Brown, H-auser, Tommasi, Cor: tt and Salvo, Tetrahedron Letters (1993), 34(3), 419-422).
(11) Scytonemin in Chlorogloeo -psis sp, (F Garcia-Pichel, N D Sherry and R W Castenholz, Photochemistry and Photobiology, 17-23, (1992)).
(1)Black pigments in conidia of Aspergillus niger gof n 0 Garcia, Environ. Entomology 21(4) 913-917(1992).
(13) UVA absorbing Compounds such as Biopterin glucoside (T Matsunaga, J G Burgess, N Yamada, K Komatsu, S Yoshida, and Y Wachi, Appl.
Microbiol.Biotechnol. (1993)39:250-253).
(14) SOD and Catalase (antioxidants) sc, cs cbose cA'c\os ed in Mycosporine amino acid (MAA) like compounds (F Garcia-Pichel and R N Castenholz, AEM 59(1), 163-169 (1993) and 59(1) 170- 176(1993)).
(16) Any other compounds which absorb preferably in the uv and 300-380 nm region of the spectrum, as these are the regions which appear to cause the most damage (Pusztai et al, Biochem. J. 1991, 273:43-47).
Introduction of genes encoding for any one of these photoprotectants or the producers thereof into a s.rain of a microorganism such as Bt will enable the microorganism to produce its own photoprotection.
Dealing firstly with Bt, the introduction of a DNA sequence or gene into a commercial strain of Bt is a well-established procedure and has been achieved at high frequencies (Shurter et al, Mol. Gen. Genet. 1989, 218:177-181; Masson, et al, FEMS Microbiol. Letts. 1989, 60:205-210). Some of the vectors that have been designed and structured for B.subtilis can replicate in Bt and several of the antibiotic resistant markers are expressed. There are also reports of vectors constructed from endogenous Bt plasmids.
Several methods to transform Bt have been reported, including transformation by conjugation, transduction and protoplast formation. However, the most successful method i that of electroporation, where the cells are exposed to rapid, high voltage ;ses. This results in transient pores appearing in the cell membranes, through which DNA is able to enter the cell. There are several published methods for transforming Bt by electroporation. The method found to give the highest and most consistent transformation frequencies (Mettus A M and Macaluso A, (1990) Appl. Environ.Microbiol. 56 1128-1134) gave
I
transformation frequencies of 10 3 to 10 4 /ug DNA for the fermentor strain 152 (ATCC55267).
For the photoprotectant to be most effective, it is preferably contained within the Bt cell and thus the Bt cell must be prevented from lysing. This can be achieved by mutating the cell so that the sporulation pathway is blocked after sporulation has been initiated (after stage II of sporulation). Alternatively, the recipient Bt cells may be mutated to be autolysin minus or deficient.
Alternatively the Bt cells may be encapsulated or their cell walls cross-linked.
Mutation is via known methods and would include the use of mutagens such as nitrosoguanadine, ethylmethylsulphonate and uv. In addition, transposon mutagenesis may also produce the required genotypes.
Suitable promoters for use in Bt and other Bacillus strains include Spo 2 (from phage spo2) and amylase (sporulation-specific).
The end result is a Bt strain which produces a photoprotectant which protects i the cells of the Bt strain against photodegredation, particularly uv-inactivation and which are also asporogenous and/or autolysin deficient, encapsulated or cross-linked, thus maintaining the crystal and the photoprotectant in the cell rather than releasing it into the culture medium. These would then be released on ingestion by the insects.
A strain of Bt having inserted into its genome a DNA sequence encoding a compound which either acts as a photoprotectant or which produces a photoprotectant, may be used in an insecticidal composition for the control of insects at a locus in a conventional manner.
The main advantage of the strain of Bt of the invention is that it is protected against photodegredation and thus should have a longer efficacy time.
An example of the cloning of a melanin producing tyrosinase gene into Bt will I- now be given.
I. Materials and Methods.: Bacterial strains, plasmids and media.: The locally isolated Bacillus thuringiensis (Bt) strain 152 (ATCC 55267) which was the subject of South African Patent Application number 93/2792, was used as recipient. The Dam Dcm-E.coli host, SCS 110 was obtained as competent cells from Stratagene.
The Bacillus subtilis expression vector pPL708 has been previously described (Duvall Williams Lovett Rudolph C, Vasantha N and Guyer M, Gene, 24, 171-177)). E.coli and Bt strains were grown in Luria broth Bacto-tryptone, 5g/l yeast extract, 10g/1 NaCI, pH 7,5) at 37°C. Where relevant, the LB was supplemented with antibiotics: neomycin was used at ampicillin was used at 100gg/ml.
DNA isolation and manipulation: The alkaline lysis method described by Birnboim and Doly (Nucleic Acids Research 7, 1513 (1979)), and the LiCI method (He et al, Nucleic Acids Research, 18(6), 1660(1990)) were used to i isolate DNA from E.coli. The plasmid pPL708 was isolated out of B.subtilis by the method of Lovett P.S and Keggins KM: in Wu R Methods in Enzymology, Vol 68. Academic Press, New York, 1979, pp 3 4 2 3 5 7 Small scale miniprep DNA was isolated out of Bt by the Lereclus modification of the Biraboim and Doly method (Lereclus et al: Mol Gen Genet 186, 391-398 (1982). Restriction enzymes (Boehringer Mannheim), calf alkaline phosphatase (Pharmacia) and T4 Ligase (Promega) were used according to the manufacturer's instructions. DNA fragments were isolated out of TAE gels and were purified using the GENECLEAN II Kit® (BIO101 Inc.). All other recombinant DNA techniques were as described in Sambrook, Maniatis and Fritsch, Molecular Cloning: A Laboratory Manual, 2nd Ed. (1989).
DNA Transformation: DNA was transformed into competent cells of the E.coli strain SCS110 according to the manufacturer's instructions (Stratagene).
The Bt strain 152 was routinely transformed by electroporation (Mettus and 12 Macaluso, Appl. Environ. Micro, 56(4), 1128-1134 (1990)).
II. Results.: The melanin operon consists of two genes- mel I and rmel II, both of which are required for the production of tyrosinase (although only mel II encodes the structural gene for tyrosinase). An E.coli construct containing the Streptomyces antibioticus melanin operon from plasmid plJ702 was used as the source of the melanin genes. The Eco construct did not contain a promoter in front of the melanin operon; thus, the genes were not expressed.
However, when this construct was ligated to the B.subtilis vector pPL708 via the Pstl restriction site on each plasmid, and transformed into SCS110, the resulting colonies expressed melanin, and were brown. The constructs were confirmed by restriction mapping. As there was evidence that DNA isolated out of a Dam-Dcm-E.coli host could be successfully transformed directly into Bt (Macaluso A and Mettus A- M, J. Bacteriol. 173(3) 1453-1356 (1991) the recombinant of (pPL708 mel) isolated out of SCS110 was transformed directly into Bt strain 152 by electroporation. Transformants were selected on SLB containing neomycin, and the presence of the melanin ge e in the transformants was confirmed by Southern blotting and hybridization to the 1,4 kb BamHI/Bcll fragment which contained the melanin genes.
Although the invention is of particular application to Bt, the invention also encompasses the provision of a microorganism which contains in its genome a first DNA sequence encoding a Bt endotoxin and a second DNA sequence encoding a compound which either acts as a photoprotectant or which produces a photoprotectant, the first and second DNA sequences being capable of expression in the microorganism.
The microorganism may be for example a bacterium, an algae, a fungi, a virus or a yeast.
Generally, the microorganism will be a bacterium such as for example Bacillus clsubtilis or E.coli or Pseudomonas.
In the case of a microorganism other than Bt, the microorganism must have inserted into it for expression both the gene for a Bt endotoxin and the gene for a compound which either acts as a photoprotectant or which produces a photoprotectant. Conventional techniques for the transformation of microorganisms can be used to achieve this.
An example of the cloning of a melanin producing tyrosinase gene and an endotoxin gene into E.coli will now be given.
I. Materials and methods.: Bacterial strains, plasmids and media: The E.coli hosts used as recipients of both the melanin and toxin genes were JM109 and JM105, obtained from the ATCC collection. The Dam-DcmE.coli host, SCS 110 was obtained as competent cells from Stratagene. The vector pTrc99A has been previously described (Amann et al, Gene 69, 301-315(1988)) and was obtained from Pharmacia. E.coli strains were grown in Luria broth (LB) (10g/l Bactotryptone, 5 g/1 yeast extract, 10 g/l NaCI, pH 7,5) supplemented with carbennicillin (200gg/ml) at 37°C. For production of melanin, the cells were S* grown on Luria Agar supplemented with 100 jig/ml ampicillin, 0,3 g/l tyrosine, 0,2 mM FeCI 3 0,2 mM CuSO 4 The melanin gene was induced by the addition of 1 mM Isopropylthio-B-galactoside (IPTG).
DNA isolation and manipulation: The alkaline lysis method described by Birnboim and Doly (Nucleic Acids Research 7, 1513(1979)), and the LiCI method (He et al, Nucleic Acid Research, 18(6), 1660(1990)) were used to isolate DNA from E.coli. Restriction enzymes (Boehringer Mannheim), calf alkaline phosphatase (Pharmacia), Klenow (Boehringer Mannheim) and T4 S Ligase (Promega) were used according to the manufacturers instructions.
DNA fragments were isolated from TAE agarose gels and were purified using the GENECLEAN II® kit (BIO 101 Inc.) All other recombinant DNA techniques were as described in Sambrook, Maniatis and Fritsch, Molecular Cloning: A Laboratory Manual 2nd ed. (1989).
DNA transformation: DNA was transformed into E.coli by the process of electroporation. Electroporation cells of E.coli strains JM105 and JM109 were made by growing the cells to an OD6oo of 0,5 to 1,0, chilling them for minutes on ice, and then harvesting them at 4000g for 15 minutes. The cells were washed once in water, and once in 10% glycerol, before being resuspended in 1:500 of the original volume. The cells were frozen in aliquots for up to 6 months. After being thawed on ice, the cells were electroporated using the BioRad Gene Pulser and Pulse Controller, according to the manufacturer's instructions. Thus, 40j1 of cells were mixed with 1-2g1 of DNA; the cells/DNA mixture was transferred to a chilled 0,2cm electroporation cuvette and placed in the chamber. Electroporation conditions were 25 AF, 2,5KV and the Pulse Controller was set at 200n. This resulted in a time constant of between 4 and 5 milliseconds. Immediately after the pulse, Iml of LB was added, and the cells were allowed to express for an hour at 37°C before being plated an Luria Agar with antibiotics.
Protein analysis: After incubation overnight, 1,5 ml of E.coli cells were harvested, and resuspended in 100/l of 3 x Laemmli buffer (Laemmli, Nature 227, 680-685(1970)). The proteins were denatured at 100 0 C for 10 minutes.
Samples were cooled and centrifuged at 12000xg for 10 minutes. Aliquots of the supernatant were analysed by SDS-PAGE electrophoresis on a 7,5% gel using a BioRad Mini PROTEAN II electrophoresis system. Once electrophoresis had been completed, the gel was reacted with an antibody solution in a Western Blot (Towbin et al, Proc. Natl, Acai, Sci, USA 76, 4350- 4354(1979)). Thus the gel was soaked in blotting solution (3 g/l Tris (hydroxymethyl)aminomethane; 14,4 g/l glycine; 10% methanol(technical grade)) for 1 hour with gentle shaking before being placed on nitrocellulose "i sheet which had been prewet in blotting buffer. The gel and membrane were sandwiched between two sheets of 3MM chromatography paper, and then between 2 pieces ol oponge. This entire sandwich was then loaded into a Mini Trans-Blot Electrophoretic Transfer Cell (BioRad) and was blotted for 1 hour at 150V. Once blotting was completed, the membrane was washed in 2% milk powder in PBS for two hours at room temperature before being incubated with the diluted antibody solution (1:200 anti-protoxin antibody in PBS containing 2% milk powder) for two hours. The membrane was then washed three times for 10 minutes each in PBS containing 0,1% Triton X-100, before being soaked for two hours in the second antibody solution (alkaline phosphatase conjugated anti-rabbit solution, diluted 1:5000 in PBS plus 2% milk powder). The membrane was then washed once with PBS containing 0,1% Triton X-100 for 30 minutes, and then with PBS for 3x10 minutes.
Freshly made staining solution (30mg P-nitro blue tetrazolium chloride (NBT) in 1ml 70% N,N-dimethylformamide; 15mg 5-bromo-4-chloro-3-indolyl phosphate toluidine salt (BCIP) in Iml 100% N,N-dimethylformamide; 98 ml carbonate buffer, pH 9.8) was added until a reaction was visible, after which the gel was rinsed in distilled water and dried between two sheets of Whatman paper in the dark.
Antibody production: The 135KDa endotoxin proteins were isolated from an SDS-PAGE gel by electroelution, and were used to immunise rabbits. Whole serum was obtained by bleeding the rabbits, and immunoglobulins were purified from the whole serum by the method of Hardie and Van Regenmortel (1977). (Isolation of specific antibody under conditions of low ionic strength. J. Immunol.Methods 15:305). The polyclonal antibodies were absorbed to E.coli cell extracts in order to reduce the background antibody activity.
UV exposure: In the case of Bt toxin, 20mg of freeze dried powder was mixed with varying amounts of melanin (0,0001%; 0,001%; 0,01%; and the mixture was resuspended in 4 ml of water. This was pipetted onto clean glass slides, and then left to dry overnight at 37°C. The slides were than exposed to 0,67 x 10' joules/m 2 of uvB light, before being resuspended in 10 ml Bioassay buffer. These samples were then tested in bioassays.
16 In the case of E.coli, the cells were incubated for 72 hours at 37°C in the presence of IPTG, CuSO 4 tyrosine and FeCI 3 When harvested, the cell pellet was brown in colour, due to the expression of the melanin gene.
Overnight cultures of E.coli did not produce brown pellets, and these cultures were used as controls.
Insect Colonies: Chilo partellus larvae were raised on the following diet: Agar 100g Water 5000ml Grated Chickpea 600g Glucose 100g Powdered milk Yeast extract Ascorbic Acid Sorbic Acid *Nipagen(Methyl-4-hydroxybenzoate/methylparaben) 1g *Cholesterol *Ether 100ml {ingredients marked were not added to media used for bioassays, but only to growth media} Chilo partellus larvae were grown on this media until they reached the second instar stage, which takes about 7 days. They were then used for bioassay tests.
Bioassays: The media indicated above was decanted into 30ml aliquots while the media was still warm (55 0 The appropriate amount of toxin was then added from stock solutions, and mixed with the media using an Ultraturrax.
S" The mixture was poured into petri dishes, and allowed to set. Once set, the media was cut into the required number of pieces, and each piece was then dispensed into a container. Ten C.partellus larvae were added to each container, and left at 25 0 C, 80% humidity for 7 days, after which the larval mortality was determined.
II. RESULTS.: The CrylA(c) gene was isolated as a 6,7kg Bam HI fragment. The Barn HI ends of the fragment were filled in using Klenow enzyme and dNTP's, and ligated using conditions that favour blunt ends to the blunt-ended Sall site of the vector pTrc99A. The vector ends were also treated with calf alkaline phosphatase to prevent recircularisation. The recombinants that contained the toxin gene were detected by gel electrophoresis of mini-prepared DNA. This result was confirmed by showing toxin expression in a Western Blot, reacted with antibodies raised to the toxin gene. One of the positive transformants which contained the desired construct, (C5) was chosen as the candidate for the introduction of the melanin gene.
The melanin operon consists of two genes- miell and inel II, both of which are required for the production of tyrosinase (although only me/Ill encodes the structural gene for tyrosinase). They were isolated as a 1,4kb BamHI/BCII fragment from an E.coli construct containing the Streptomyces antibioticus melanin operon from plasmid pIJ702. To overcome the problems of Bcll sensitivity to methylation, 'he construct was transformed into and isolated out of the Dam'Dcm- strain, SCSI10. The isolated fragment was ligated into the alkaline phosphatased BamHI site of the toxin-containing plasmid C5. This results in the melanin gene being inserted behind the strong pTrc promoter which is inducible by IPTG. Recombinants containing the melanin gene were selected by the brown pigment production in the presence of IPTG, CuSO 4 tyrosine and FeCI 3 The constructs were confirmed by mapping the DNA.
The expression of the toxin gene in the presence of melanin was confirmed by Western Blotting which indicated that the E.coli with both melanin and toxin genes showed levels of toxin expression similar to those found in E.coli with the toxin alone.
i 18 BIOASSAYS RESULTS In bioassays against second instar Chilo partellus larvae, the protective effect of melanin during ultraviolet light exposure was demonstrated by mixing pure melanin from Sepia officinalis (obtained from Sigma (M2649)) at various concentrations with Bt toxin, which was used at 120Ig/ml. The mixtures were then exposed to doses of 0,67x10 5 joules/m 2 from a Philips TL40W/12 lamp, which transmits ultraviolet light in the UVB range. This region includes the shortest wavelengths found in sunlight at the earth's surface. Thus, this lamp, with an emission peak of 313nm, simulates the damage caused by sunlight.
When the melanin-containing samples were bioassayed after being exposed to uv, the samples containing melanin at 0,1% gave 57,9% protection over controls, Those samples with melanin at 0,01% gave 26,3% protection.
In the bioassays of E.coli cells which contain the toxin and melanin genes, the melanin was shown to have a protective effect (Table 1).
o TABLE 1 Strain No of Larvae No Dead Killing Mean Killing 1 10 2 10 4 40 4 6 92,5
A
M
3 10 6 8 80 6 8 c3 4 10 6 7 70 77,5 9 9 10 6 1 10 26,7 1 Strain 1 Strain 2 Strain 3 r o o E.coli containing the toxin gene and then exposed to uv.
E.coli containing the toxin gene and not exposed to uv.
S E.coli containing the melanin and toxin genes and exposed to uv.
E.coli containing the melanin and toxin genes and not exposed to uv.
S E.coli containing only the melanin gene.
Strain 4 Strain 5 cc o Concentration used: 10 mg/ml The endotoxin gene used in the above example is the CrylA(c) gene whose nucleotide sequence is disclosed in "Biological control of Eldana Saccharina Walker (Lepidoptera:Pyralidae) using a cloned Bacillus Thuringiensis deltaendotoxin gene", by Gerardo Herrera, PhD Thesis (submitted), University of Cape Town, 1994.
~I
Any other suitable endotoxin gene may be used, for example the gene disclosed in Characterized full length and truncated plasmid clones of the crystal protein of Bacillus thuringiensis susp. Kurstaki HD-73 and their toxicity to Manduce sexta, by M J Adana, M J Stauer, A Rocheleau, J Leighton, R F Barker and D V Thompson, Gene 36:289-309, (1985).
The melanin producing gene may be any suitable melanin or melanin-like producing gene such as for example the tyrosinase gene having the nucleotide sequence set out in "The nucleotide sequence of the tyrosinase gene from Streptomyces antibioticus and characterization of the gene product", V Bernan, D Filipula, W Herber, M Bibb and E Katz, Gene 37 (1985), 101-110.
Suitable promoters for E.coli include lac, trp of E.coli and P, of Hybrid promoters include the tac promoter of E.coli (hybrid of trp and lac), trc promoter, tic promoter and Ipp promoter.
Suitable terminators, when such are required, for E.coli include the terminator of ribosomal RNA operon, rrn B, phage Id DNA, trp attenuator and Ipp terminator.
*o
Claims (11)
1. A microorganism containing in its genome a first DNA sequence encoding a Bacillus thuringiensis endotoxin and a second DNA sequence encoding a compound which either acts as a photoprotectant or which produces a photoprotectant, the photoprotectant being selected from the group consisting of melanin, an indole, a carotenoid, SOD and catalase, the first and second DNA sequences being capable of expression in he microorganism.
2. A microorganism according to claim 1 wherein the microorganism is a bacterium,
3. A microorganism according to claim 2 wherein the bacterium is a strain of Bt.
4. A microorganism according to claim 3 wherein the Bt is asporogenous and/or autolysin deficient. A microorganism according to claim 2 wherein the bacterium is E.coli.
6. A microorganism according to any one of claims 1 to 5 wherein the photoprotectant absorbs radiation in the uv and 300 to 380 nm region of the spectrum.
7. A microorganism according to any one of claims 1 to 5 wherein the compound which acts as a photoprotectant is a carotenoid.
8. A microorganism according to any one of claims 1 to 5 wherein the compound which produces a photoprotectant is selected from the group consisting of tyrosinase which produces melanin and indole dioxygenase which produces indigo.
9. A microorganism transformation vector carrying an expression cassette including a first DNA sequence encoding a Bt endotoxin and a second DNA sequence encoding a compound which either acts as a photoprotectant or which produces a photoprotectant, the photoprotectant being selected from the group consisting of melanin, an indole, a carotenoid, SOD and catalase, and at least one promoter and optionally a terminator for each DNA sequence.
10. A vector according to claim 9 for E.coli. ,p RA4 (it 0 X ^W"9 22
11. A vector according to any one of claims 9 or wherein the photoprotectant absorbs radiation in the uv and
300-380 nm region of the spectrum. 12. A vector according to any one of claims 1 to wherein the compound which acts as a photoprotectant is a carotenoid. 13. A vector according to any one of claims 9 or wherein the compound which produces a photoprotectant in selected from the group consisting of tyrosinese which produces melanin and indole dioxygenase which produces indigo. 14. A method of produc:ng a microorganism which expresses a Bt endotoxin and a compound which either acts as a photoprotectant or which produces a photoprotectant S* 15 the photoprotectant being selected from the group consisting of melanin, an indole, a carotenoid, SOD and catalase, including the step of transforming a cell of the microorganism by inserting into the genome of the cell a first DNA sequence encoding a Bt endotoxin and a second DNA 20 sequence encoding a compound which either acts as a photoprotectant or which produces a photoprotectant under the transcriptional and translational control of transcriptional and translational initiation and termination regulatory regions which function in the cell. 15. A method according to claim 14 wherein the microorganism is a bacterium. 16. A method according to claim 15 wherein the microorganism is E.coli. 17. A method according to any one of claims 14 to 16 wherein the photoprotectant absorbs radiation in the uv and 300 to 380 nm region of the spectrum. 18. A method according to any one of claims 14 to 16 wherein the photoprotectant is a carotenoid. 19. A method according to any one of claims 14 to 16 wherein the compound which produces a photoprotectant is selected from the group consisting of tyrosinase which produces melanin and indole dioxygenase which produces 23 indigo. A zethod of conferring resistance to photodegredation on a strain of Bt strain by inserting into the genome of the Bt cell a DNA sequence which encodes a compound which either acts as a photoprotectant or which produces a photoprotectant the photoprotectant being selected from the group consisting of melanin, an indole, a carotenoid, SOD and catalase under the transcriptional and translational coitrol of transcriptional and translational initiation and termination regulatory regions which function in the Bt cell. 21. A method according to claim 20 wherein the photoprotectant absorbs radiation in the uv and 300 to 380 m region of the spectrum. 22. A method according to claim 20 wherein the photoprotectant is a carotenoid. 23. A method according to claim 20 wherein the compound which produces a photoprotectant is selected from the group consisting of tyrosinase which produces melanin 20 and indole dioxygenase which produces indigo. 24. An insecticidal composition containing as its Sactive ingredient a Bt endotoxin and a photoprotectant the photoprotectant being selected from the group consisting of melanin, an indole, a carotenoid, SOD and catalase, the Bt endotoxin and the photoprotectant or a compound which produces the photoprotectant having been expressed by the same microorganism. An insecticidal composition according to claim 24 wherein the microorganism is a bacterium. 26. An insecticidal composition according to claim wherein the microorganism is a strain of Bt. 27. An insecticidal composition according to claim wherein the microorganism is E.coli. 28. An insecticidal composition according to any one of claims 24 to 27 wherein the photoprotectant absorbs radiation in the uv and 300 to 380 nm region of the spectrum. 24 29. An insecticidal composition according to any one of claims 24 to 27 wherein the photoprotectant is a carotenoid. An insecticidal composition according to any one of claims 24 to 27 wherein the compound which produces a photoprotectant is selected from the group consisting of tyrosinase which produces melanin an indole dioxygena'e which produces indigo. 31. An insecticidal composition containing as its active ingredient a strain of Bt which includes in its genome a DNA sequence encoding a compound which either acts .as a photoprotectant or which produces a photoprotectant, the photoprotectant being selected from the group consisting of melanin, an indole, a carotenoid, SOD and S 15 catalase. 32. An insecticidal composition according to claim 31 wherein the Bt strain is asporogenous and/or autolysin o: deficient, or encapsulated or cross-linked. 33. An insecticidal composition containing as its 20 active ingredient the spores obtained from a culture of a strain of Bt which includes in its genome a DNA sequence encoding a compound which either acts as a photoprotectant or which produces a photoprotectant after sporogenesis, the photoprotectant being selected from the group consisting of melanin, an indole, a carotenoid, SOD and catalase. 34. An insecticidal composition containing as its active ingredient an endotoxin produced by a culture of a strian of Bt which includes in its genome a DNA sequence encoding a compound which either acts as a photoprotectant or which produces a photoprotectant, and the photoprotectant, the photoprotectant being selected from the group consisting of melanin, an indole, a carctenoid, SOD and catalase. An insecticidal composition according to any one of claims 31 to 34 wherein the photoprotectant absorbs radiation in the uv and 300 to 380 nm region of the spectrum. 25 36. An insecticidal composition according to any one of claims 31 to 34 wherein the photoprotectant is a carotenoid. 37. An insecticidal composition according to any one of claim 31 to 34 wherein the compound which produces a photoprotectant is selected from the group consisting of tyrosinase which produces melanin and indole dioxygenase which produces indigo. 38. A method for controlling insects at a locus which includes the step of treating the locus to be protected with an amount of an insecticidal composition according to any one of claims 24 to 37. 39. A method according to claim 38 wherein the insects are of the order Lepidoptera, Diptera or Coleoptera. A recombinant DNA sequence comprising a first DNA sequence encoding a Bt endotoxin and a second DNA sequence encoding a compound which eit' er acts :9 a photoprotectant or which produces a photoprotectant, the photoprotectant 20 being selected from the group consisting of melanin, an indole, a carotenoid, SOD and catalase. DATED THIS 5TH DAY OF SEPTEMBER 1996 AECI LIMITED By Its Patent Attorneys: GRIFFITH HACK CO., Fellows Institute of Patent Attorneys of Australia ABSTRACT This invention discloses a microorganism, preferably a bacterium, containing in its genome a first DNA sequence encoding a Bacillus thuringiensis endotoxin and a second DNA sequence encoding a compound which either acts as a photoprotectant or which produces a photoprotectant, the first and second DNA sequences being capable of expression in the microorganism. The photoprotectant is designed to protect either the microorganism itself or the endotoxin produced by the microorganism from photodegredation. The invention also covers insecticidal compositions containing the microorganism or the products thereof and the use of the insecticidal composition for controlling insects. 0 *0000
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ZA933451 | 1993-05-18 | ||
ZA93/3451 | 1993-05-18 |
Publications (2)
Publication Number | Publication Date |
---|---|
AU6308194A AU6308194A (en) | 1994-11-24 |
AU673591B2 true AU673591B2 (en) | 1996-11-14 |
Family
ID=25582861
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU63081/94A Ceased AU673591B2 (en) | 1993-05-18 | 1994-05-16 | Photoprotected bacillus thuringiensis toxin |
Country Status (6)
Country | Link |
---|---|
AP (1) | AP498A (en) |
AU (1) | AU673591B2 (en) |
BR (1) | BR9401993A (en) |
CA (1) | CA2123669A1 (en) |
OA (1) | OA09940A (en) |
ZA (1) | ZA943344B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9609095D0 (en) * | 1996-05-01 | 1996-07-03 | Univ Waterloo | A new, pigment-producing, strain of bacillus thuringiensis |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2686975B2 (en) * | 1987-09-14 | 1997-12-08 | アルコ・ケミカル・カンパニー | Collection method of chiral epoxy alcohol in asymmetric epoxidation method |
US5147640A (en) * | 1988-11-07 | 1992-09-15 | Ecogen Inc. | Strains of bacillus thuringiensis insecticidal compositions containing the same |
US5262324A (en) * | 1991-11-06 | 1993-11-16 | Mycogen Corporation | Coleopteran-active Bacillus thuringiensis isolates and genes encoding coleopteran-active toxins |
-
1994
- 1994-05-13 AP APAP/P/1994/000646A patent/AP498A/en active
- 1994-05-16 ZA ZA943344A patent/ZA943344B/en unknown
- 1994-05-16 CA CA002123669A patent/CA2123669A1/en not_active Abandoned
- 1994-05-16 AU AU63081/94A patent/AU673591B2/en not_active Ceased
- 1994-05-17 OA OA60512A patent/OA09940A/en unknown
- 1994-05-17 BR BR9401993A patent/BR9401993A/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ZA943344B (en) | 1995-01-16 |
AP9400646A0 (en) | 1994-07-31 |
AU6308194A (en) | 1994-11-24 |
BR9401993A (en) | 1994-12-13 |
AP498A (en) | 1996-05-29 |
OA09940A (en) | 1994-11-15 |
CA2123669A1 (en) | 1994-11-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100241117B1 (en) | Novel microorganism and insecticide | |
Bourgouin et al. | Transfer of the toxin protein genes of Bacillus sphaericus into Bacillus thuringiensis subsp. israelensis and their expression | |
AU629349B2 (en) | Bacterial genes | |
White Jr et al. | Occurrence of B acillus amyloliquefaciens as a systemic endophyte of vanilla orchids | |
EP0405810B1 (en) | Novel bacillus thuringiensis isolate active against lepidopteran pests, and genes encoding novel lepidopteran-active toxins | |
US5126133A (en) | Bacillus thuringiensis isolate active against lepidopteran pests, and genes encoding novel lepidopteran-active toxins | |
US5281532A (en) | Pseudomas hosts transformed with bacillus endotoxin genes | |
JPH0558833A (en) | Novel bacillus thuringiensis isolation body active in control of new noxious diptera | |
EP0366397B1 (en) | Novel bacillus thuringiensis isolate denoted B.t. PS81F, active against lepidopteran pests, and a gene encoding a lepidopteran-active toxin | |
Sudha et al. | Introduction and expression of the cry1Ac gene of Bacillus thuringiensis in a cereal-associated bacterium, Bacillus polymyxa | |
Fischer et al. | Introduction of plasmid pC194 into Bacillus thuringiensis by protoplast transformation and plasmid transfer | |
Liu et al. | Efficient synthesis of mosquitocidal toxins in Asticcacaulis excentricus demonstrates potential of gram-negative bacteria in mosquito control | |
KR20200106171A (en) | Auxotrophic strain of Staphylococcus bacteria | |
Wiwat et al. | Expression of chitinase-encoding genes from Aeromonas hydrophila and Pseudomonas maltophilia in Bacillus thuringiensis subsp. israelensis | |
KR0133924B1 (en) | Transformation method of bacillus thuringiensis | |
US5516693A (en) | Hybrid gene incorporating a DNA fragment containing a gene coding for an insecticidal protein, plasmids, transformed cyanobacteria expressing such protein and method for use as a biocontrol agent | |
AU673591B2 (en) | Photoprotected bacillus thuringiensis toxin | |
US5246852A (en) | Bacillus thuringiensis isolate active against lepidopteran pests, and genes encoding novel lepidopteran-active toxins | |
JPH0358904A (en) | New bacillus thurinqiensis chorista | |
Honigman et al. | Cloning and expression of the lepidopteran toxin produced by Bacillus thuringiensis var. thuringiensis in Escherichia coli | |
KR19990069306A (en) | Endotoxin protein of Bacillus thuringiensis ENT 0423 strain and microbial insecticide using the same | |
EP0777734B1 (en) | New polypetides having a toxic activity against insects of the dipter family | |
Shi et al. | Cloning and expression of the binary toxin gene from Bacillus sphaericus IAB872 in a crystal-minus Bacillus thuringiensis subsp. israelensis | |
Wiwat et al. | Inhibition of a conjugation-like gene transfer process in Bacillus thuringiensis subsp. israelensis by the anti-S-layer protein antibody | |
US6335008B1 (en) | Hybrid genes incorporating a DNA fragment containing at least one gene encoding an insecticidal protein and a gene encoding a glutamine synthase inhibitor, plasmids, transformed cyanobacteria expressing such proteins and method for use as biocontrol agent |